SMMT
$16.76+0.42%
as of close, Oct 2, 2026
☾ AH $16.76 +0.42%
Summit Therapeutics Inc. Common StockStock · Health CareNasdaq Composite 0.03%Russell 1000 0.002%US Stock Market 0.002%Russell 3000 0.002%
Summit Therapeutics Inc. Common Stock returns by year
As of market close, Oct 2, 2026
Summit Therapeutics Inc. Common Stock returns by year (2016–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $17.49 | $16.76 | 0.0% | -4.2% | |
| 2025 | $17.85 | $17.49 | 0.0% | -2.0% | |
| 2024 | $2.61 | $17.85 | 0.0% | +583.7% | |
| 2023 | $4.25 | $2.61 | 0.0% | -38.6% | |
| 2022 | $2.69 | $4.25 | 0.0% | +58.0% | |
| 2021 | $4.70 | $2.69 | 0.0% | -42.8% | |
| 2020 | $1.60 | $4.70 | 0.0% | +193.8% | |
| 2019 | $1.15 | $1.60 | 0.0% | +39.1% | |
| 2018 | $11.08 | $1.15 | 0.0% | -89.6% | |
| 2017 | $8.56 | $11.08 | 0.0% | +29.4% | |
| 2016 | $11.50 | $8.56 | 0.0% | -25.6% |
- Annualized
- +2.7%
- 2016–2026
- Average year
- +70.5%
- 10 full years
- Best year
- +583.7%
- 2024
- Worst year
- -89.6%
- 2018
- Positive years
- 5/10
- 50% up
Annualized (CAGR)
+2.7%
2016–2026
Average year
+70.5%
10 full years
Best year
+583.7%
2024
Worst year
-89.6%
2018
Positive years
5/10
50% up
Total return by period#
Annual
-400%-200%0%200%400%
2016-26%'16
2017+29%'17
2018-90%'18
2019+39%'19
2020+194%'20
2021-43%'21
2022+58%'22
2023-39%'23
2024+584%'24
2025-2.0%'25
2026-4.2%'26
Methodology#
Total returns, dividends reinvested, measured on SMMT. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Summit Therapeutics Inc. Common Stock's average annual return?
- Since 2016, Summit Therapeutics Inc. Common Stock (SMMT) has returned about 2.7% a year (the compound annual growth rate) and an average calendar-year return of 70.5%.
- What were Summit Therapeutics Inc. Common Stock's best and worst years?
- Over 2016–2026, the best year was 2024 (+583.7%) and the worst was 2018 (-89.6%).
- How often is Summit Therapeutics Inc. Common Stock up in a year?
- 5 of the 10 full years since 2016 were positive — about 50% of the time.
More on Summit Therapeutics Inc. Common Stock
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100